Welcome to BioMarket Group!

The China Pharmaceutical Market:A Strategic Opportunity Analysis

Additional Information

Published Date Jan 1, 2007
Special Offer No
Pages No
PDF Fact Sheet View Fact Sheet for the report The China Pharmaceutical Market:A Strategic Opportunity Analysis in PDF format.
Published on Date No
Format No
Publisher N/A
Product Line No
Full Title No

Availability: In stock

$1,200.00

Quick Overview

The report discusses the whole of the Chinese pharmaceutical market, taking readers through the history and current state of the healthcare system through to the regulations governing the country and its growing R&D capabilities. China has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around $US12 billion.
Request free sample pages from The China Pharmaceutical Market:A Strategic Opportunity Analysis

China has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around $US12 billion.

Factors fuelling the developmental growth and attracting foreign investors to the area include low labor costs, high quality clinical data and an abundance of R&D collaborative opportunities and facilities.

Global biotechnology within China has also undergone significant growth, promising enormous potential for new companies. Biotechnology companies in the country have already grown quicker than pharmaceutical companies.

The report discusses the whole of the Chinese pharmaceutical market, taking readers through the history and current state of the healthcare system through to the regulations governing the country and its growing R&D capabilities. Detailing the driving forces behind the pharma market and including a full breakdown of the biopharma opportunities, including the contacts of active Chinese companies, the report is an essential resource to understand and access this lucrative market.

Reasons to purchase this report:

  • Identify key partners
  • Assess the current market opportunity
  • Learn how newly implemented government changes have altered the face of the industry
  • Understand the organization and success of clinical trials in China
  • Create strategies for profitable market access into China
  • The Chinese government also plays an instrumental role in the pharmaceutical development of China. The introduction of WTO guidelines and protection for intellectual property rights has caused a shift in the company structures of China, forcing some to close business or enter into new collaborations.

    Ideally suited for individuals wishing to introduce their companies into this emerging market or review the opportunities available, this report provides a perfect resource to identify the current pattern of the market and understand the regulations that operate within the country.

Request free sample pages from The China Pharmaceutical Market:A Strategic Opportunity Analysis

Other selected research from the 'Licensing' category:


Partnering Agreements with Eisai 2010
The Partnering Agreements with Eisai 2010 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.
This report provides all the information you require to better understand Eisai Labs and its partnering interests and activities over the past five years.
Learn More


Partnering Agreements with CSL 2010
The Partnering Agreements with CSL 2010 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.
This report provides all the information you require to better understand CSL Labs and its partnering interests and activities over the past five years.
Learn More

Other selected research from the 'China' category:


Pharmaceuticals in China
Pharmaceuticals in China industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. Learn More


Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
Datamonitor’s Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report... Learn More